M Ventures
Investor profile
Venture capital
M Ventures has backed 29 European tech companies across 33 funding rounds between 2018 and 2026, joining rounds totalling €1.3B. Most active in Healthtech and Cleantech. Data as of 4 Nov 2026.
Deals
33
distinct rounds
Companies
29
backed
Active span
2018–2026
9 yrs
Total round €
€1.3B
sum of rounds joined
Deals by year
distinct rounds / yearM Ventures — deals by year — interactive chart.
Data table
| M Ventures — deals by year | |
|---|---|
| 2018 | 2 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 3 |
Top sectors
by dealsM Ventures — top sectors — interactive chart.
Data table
| M Ventures — top sectors | |
|---|---|
| Healthtech | 26 |
| Cleantech | 2 |
| Semiconductors | 2 |
| Agritech | 1 |
| Foodtech | 1 |
| Hardware | 1 |
| Robotics | 1 |
Stages
by dealsM Ventures — stages — interactive chart.
Data table
| M Ventures — stages | |
|---|---|
| Series B | 10 |
| Other | 7 |
| Series A | 7 |
| Seed | 5 |
| Series C | 3 |
| Series D+ | 1 |
Countries
by dealsM Ventures — countries — interactive chart.
Data table
| M Ventures — countries | |
|---|---|
| UK | 14 |
| France | 5 |
| Germany | 5 |
| Switzerland | 5 |
| Netherlands | 2 |
| Denmark | 1 |
| Israel | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Pfizer Ventures7
- EQT Life Sciences3
- Illumina Ventures3
- IP Group PLC3
- Novartis Venture Fund3
- Octopus Ventures3
- Taiho Ventures3
- +ND Capital2
- Andera Partners2
- ARCH Venture Partners2
- BGF2
- Bpifrance2
- Cambridge Innovation Capital2
- High-Tech Gründerfonds (HTGF)2
- INKEF Capital2
- IQ Capital2
- Longwall Ventures2
- Lowercarbon Capital2
- Omega Funds2
- OMX Ventures2
- Schroders Capital2
- Sofinnova Partners2
- UTokyo Innovation Platform2
- Ysios Capital2
- 3B Future Health Fund1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| DNA Script | France | 1 | €142M |
| Nouscom | Switzerland | 1 | €120M |
| Artios | UK | 1 | €99M |
| iOnctura | Switzerland | 1 | €80M |
| Galecto Biotech | Denmark | 1 | €79M |
| Storm Therapeutics | UK | 2 | €76M |
| Lightcast Discovery | UK | 2 | €68M |
| IOmx Therapeutics | Germany | 1 | €65M |
| NRG Therapeutics | UK | 1 | €58M |
| ReproNovo | Switzerland | 1 | €57M |
| FoRx Therapeutics | Switzerland | 2 | €53M |
| Formo | Germany | 1 | €42M |
| LabGenius | UK | 1 | €41M |
| Mosa Meat | Netherlands | 1 | €40M |
| Nucleome Therapeutics | UK | 1 | €38M |
| Enara Bio | UK | 1 | €29M |
| Trimtech Therapeutics | UK | 1 | €29M |
| Micropsi | Germany | 1 | €26M |
| Wiliot | Israel | 1 | €26M |
| NanoSyrinx | UK | 2 | €19M |
| Astraveus | France | 1 | €17M |
| Iktos | France | 1 | €16M |
| beeOLED | Germany | 1 | €13M |
| Anavo Therapeutics | Netherlands | 1 | €8.5M |
| Abselion | UK | 1 | €8.0M |
| Scipio Bioscience | France | 1 | €6.0M |
| IonKraft | Germany | 1 | €3.5M |
| aveni | France | 1 | €600k |
| Theolytics | UK | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| DNA Script | Series C | €142M | 2021-10 |
| Artios | Series D+ | €99M | 2025-11 |
| iOnctura | Series B | €80M | 2024-06 |
| Galecto Biotech | Series C | €79M | 2018-10 |
| IOmx Therapeutics | Series B | €65M | 2021-10 |
| NRG Therapeutics | Series B | €58M | 2025-09 |
| ReproNovo | Series A | €57M | 2025-05 |
| Storm Therapeutics | Series C | €48M | 2026-04 |
| Lightcast Discovery | Series B | €45M | 2023-08 |
| FoRx Therapeutics | Series A | €43M | 2025-12 |